Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases

Karla Ramos-Torres, Yu-Peng Zhou, Bo Yeun Yang, Nicolas Guehl, Sanjay Telu, Marc Normandin, Victor Pike and Pedro Brugarolas
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 619;
Karla Ramos-Torres
1Harvard Medical School Boston MA United States
2Gordon Center for Medical Research Massachusetts General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu-Peng Zhou
1Harvard Medical School Boston MA United States
2Gordon Center for Medical Research Massachusetts General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Yeun Yang
3National Institute of Mental Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Guehl
1Harvard Medical School Boston MA United States
2Gordon Center for Medical Research Massachusetts General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay Telu
3National Institute of Mental Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Normandin
2Gordon Center for Medical Research Massachusetts General Hospital Boston MA United States
1Harvard Medical School Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Pike
3National Institute of Mental Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Brugarolas
1Harvard Medical School Boston MA United States
2Gordon Center for Medical Research Massachusetts General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 619

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Karla Ramos-Torres1,2,
  2. Yu-Peng Zhou1,2,
  3. Bo Yeun Yang3,
  4. Nicolas Guehl1,2,
  5. Sanjay Telu3,
  6. Marc Normandin2,1,
  7. Victor Pike3 and
  8. Pedro Brugarolas1,2
  1. 1Harvard Medical School Boston MA United States
  2. 2Gordon Center for Medical Research Massachusetts General Hospital Boston MA United States
  3. 3National Institute of Mental Health Bethesda MD United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 20203300
Jun 20207100
Jul 20204000
Aug 20202900
Sep 20201000
Oct 20201600
Nov 2020900
Dec 20201800
Jan 20211300
Feb 20211100
Mar 20211600
Apr 2021900
May 20211300
Jun 2021700
Jul 2021300
Aug 20211200
Sep 2021600
Oct 2021300
Nov 2021300
Dec 2021500
Jan 2022700
Feb 2022600
Mar 2022600
Apr 20223200
May 2022700
Jun 2022900
Jul 2022700
Aug 20221300
Sep 2022700
Oct 2022300
Nov 2022700
Dec 2022800
Jan 2023900
Feb 2023900
Mar 2023800
Apr 2023300
May 2023100
Jun 2023700
Jul 2023300
Aug 2023200
Sep 2023500
Oct 2023800
Nov 2023500
Dec 2023300
Jan 2024700
Feb 2024200
Mar 2024600
Apr 2024300
May 20241000
Jun 2024600
Jul 2024200
Aug 2024800
Sep 2024800
Oct 2024400
Nov 2024300
Dec 2024300
Jan 2025300
Feb 2025500
Mar 2025300
Apr 20251000
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
Karla Ramos-Torres, Yu-Peng Zhou, Bo Yeun Yang, Nicolas Guehl, Sanjay Telu, Marc Normandin, Victor Pike, Pedro Brugarolas
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 619;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
Karla Ramos-Torres, Yu-Peng Zhou, Bo Yeun Yang, Nicolas Guehl, Sanjay Telu, Marc Normandin, Victor Pike, Pedro Brugarolas
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 619;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Assessment of α4β2 nicotinic acetylcholine receptor (nAChR) availability and neuronal response to rewarding food-cues in human obesity using simultaneous PET-MRI
  • Bridging brain structural/functional connectivity and tau load in PSP: A [18F]PI-2620 PET/MRI study
  • MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

New Radiotracers

  • Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
  • Design of calcium-sensing receptor targeted thera(g)nostic agents
  • Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
Show more New Radiotracers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire